PHR
Undervalued by 17.9% based on the discounted cash flow analysis.
Market cap | $1.46 Billion |
---|---|
Enterprise Value | $1.41 Billion |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1.02 |
Beta | 0.74 |
Outstanding Shares | 58,277,812 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -24.39 |
---|---|
PEG | 30.81 |
Price to Sales | 3.6 |
Price to Book Ratio | 6.31 |
Enterprise Value to Revenue | 3.37 |
Enterprise Value to EBIT | -25.82 |
Enterprise Value to Net Income | -25 |
Total Debt to Enterprise | 0.03 |
Debt to Equity | 0.16 |
No data
No data
Phreesia gives healthcare organizations a suite of robust applications to manage the patient intake process. Our innovative SaaS platform engages patients and provides a modern, convenient experience, while enabling our clients to optimi...